To establish a Rare Disease Therapeutics Corporation to encourage the development of high-risk, high-return therapies for rare diseases, and for other purposes.
USA115th CongressHR-6801| House
| Updated: 9/13/2018
Juan Vargas
Democratic Representative
California
Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Rare Disease Fund Act of 2018 or the RaD Fund Act of 2018 This bill requires the Department of the Treasury to organize the Rare Disease Therapeutics Corporation to purchase rights to, fund the development of, and sell ownership interests in drugs, biological products, and medical devices for rare diseases.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Health
Advisory bodiesDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationDrug therapyHealth programs administration and fundingHealth technology, devices, suppliesMedical researchNational Institutes of Health (NIH)Research administration and fundingResearch and development
To establish a Rare Disease Therapeutics Corporation to encourage the development of high-risk, high-return therapies for rare diseases, and for other purposes.
USA115th CongressHR-6801| House
| Updated: 9/13/2018
Rare Disease Fund Act of 2018 or the RaD Fund Act of 2018 This bill requires the Department of the Treasury to organize the Rare Disease Therapeutics Corporation to purchase rights to, fund the development of, and sell ownership interests in drugs, biological products, and medical devices for rare diseases.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Juan Vargas
Democratic Representative
California
Energy and Commerce Committee
Health
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Advisory bodiesDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationDrug therapyHealth programs administration and fundingHealth technology, devices, suppliesMedical researchNational Institutes of Health (NIH)Research administration and fundingResearch and development